Summary
- Current Price
- As of today, TWST price is $151.33, down -0.35% on
- Current Price All-Time High
- TWST price is currently -31.12% below its historical high of $219.71 set on
- Market Cap
- TWST current market cap is $10B, up +441.68% over the past 365 days
- Revenue
- TWST current annual revenue is $376.57M, up +20.32% year-over-year
- Next Earnings
- The next earnings release for TWST is on
Profile
| Metric | Value |
|---|---|
| Full Name | Twist Bioscience Corporation |
| Ticker | NASDAQ: TWST |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | twistbioscience.com |
| Employees | 923 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $151.33 | |
| Price, 1D Change | -0.35% | |
| Market Cap | $10B | |
| - | ||
| PE Ratio | - | |
| Beta | 2.60 | |
| Revenue | $376.57M | |
| Revenue, 1Y Change | +20.32% | |
| EPS | -$1.30 | |
| EPS, 1Y Change | +63.90% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$1.30 | |
| EPS Estimate | -$0.96 | |
| EPS Est. Change | +26.10% | |
| Revenue | $376.57M | |
| Revenue Estimate | $456.33M | |
| Revenue Est. Change | +21.18% | |
| Current Price | $151.33 | |
| Price Target | $150.00 | - |
| Price Tgt. Change | -0.88% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.45 | -$3.60 | -4.43% | |
| -$1.34 | -$1.30 | +3.08% | |
| -$0.96 | N/A | +26.10% | |
| -$0.40 | N/A | +69.20% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $310.76M | $312.97M | +0.71% | |
| $374.97M | $376.57M | +0.43% | |
| $456.33M | N/A | +21.18% | |
| $548.33M | N/A | +45.61% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +395.35% | |
| Price, 3Y | +791.22% | |
| Market Cap, 1Y | +441.68% | |
| Market Cap, 3Y | +926.62% | |
| Revenue, 1Y | +20.32% | |
| Revenue, 3Y | +84.99% | |
| EPS, 1Y | +63.90% | |
| EPS, 3Y | +67.88% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $151.33 | |
| SMA 200 | $81.62 | |
| SMA 50 | $145.87 | |
| EMA 200 | $94.98 | |
| EMA 50 | $146.06 | |
| MACD | $4.24 | |
| Beta | 2.60 | |
| ATR | $14.45 | |
| 14-Day RSI | 45.98 | |
| 10-Day Volatility | 119.66% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $376.57M | |
| EPS | -$1.30 | |
| Gross Profit | $191.00M | |
| Gross Margin | 50.72% | |
| Operating Income | -$136.26M | |
| Operating Margin | -36.18% | |
| Net Income | -$77.67M | |
| Net Margin | -20.63% | |
| EBITDA | -$111.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.16 | |
| 3.64 | ||
| 3.33 | ||
| - | ||
| 2 | ||
| 33.10 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 23.24 | ||
| 22.51 | ||
| -88.63 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $472.96M | |
| $232.43M | ||
| $641.86M | ||
| $332.97M | ||
| $168.90M | ||
| $91.41M | ||
| Total Debt | $75.57M | |
| $13.82M | ||
| $11.09M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $454.24M | ||
| $327.26M | ||
| $185.57M | ||
| $0.00 | ||
| $24.85M | ||
| $0.00 | ||
| $719.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$47.63M | ||
| -$24.76M | ||
| $28.54M | ||
| Capex | $28.00M | |
| -$75.63M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Jefferies | ||
| Barclays | → | |
| Guggenheim | → | |
| Leerink Partners | → | |
| BWS Financial | → | |
| Leerink Partners | → | |
| UBS | ||
| BWS Financial | ||
| Piper Sandler | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
No data
Screeners with TWST
FAQ
- What is the ticker symbol for Twist Bioscience Corporation?
- The ticker symbol for Twist Bioscience Corporation is NASDAQ:TWST
- Does Twist Bioscience Corporation pay dividends?
- No, Twist Bioscience Corporation does not pay dividends
- What sector is Twist Bioscience Corporation in?
- Twist Bioscience Corporation is in the Healthcare sector
- What industry is Twist Bioscience Corporation in?
- Twist Bioscience Corporation is in the Biotechnology industry
- What country is Twist Bioscience Corporation based in?
- Twist Bioscience Corporation is headquartered in United States
- When did Twist Bioscience Corporation go public?
- Twist Bioscience Corporation initial public offering (IPO) was on October 31, 2018
- Is Twist Bioscience Corporation in the S&P 500?
- No, Twist Bioscience Corporation is not included in the S&P 500 index
- Is Twist Bioscience Corporation in the NASDAQ 100?
- No, Twist Bioscience Corporation is not included in the NASDAQ 100 index
- Is Twist Bioscience Corporation in the Dow Jones?
- No, Twist Bioscience Corporation is not included in the Dow Jones index
- When was Twist Bioscience Corporation last earnings report?
- Twist Bioscience Corporation's most recent earnings report was on August 3, 2026
- When does Twist Bioscience Corporation report earnings?
- The next expected earnings date for Twist Bioscience Corporation is November 16, 2026
Data Sources & References
- TWST Official Website www.twistbioscience.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1581280/000158128025000025/0001581280-25-000025-index.htm
- TWST Profile on Yahoo Finance finance.yahoo.com/quote/TWST
- TWST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/twst